The l-arginine/NO pathway in the MELAS syndrome: An insufficiently explored and controversial research area.
暂无分享,去创建一个
D. Tsikas | M. Obermann | A. Das | C. Herrmann | E. Hanff | A. Kayacelebi
[1] J. Finsterer,et al. Levels of nitric oxide pathway parameters may depend on heteroplasmy rates of the m.3243A>G mutation. , 2017, International Journal of Cardiology.
[2] D. Tsikas,et al. Unaltered l-arginine/NO pathway in a MELAS patient: Is mitochondrial NO synthase involved in the MELAS syndrome? , 2016, International journal of cardiology.
[3] J. Finsterer,et al. In the heart of MELAS syndrome. , 2016, International journal of cardiology.
[4] H. Reichmann,et al. Thinking beyond borders. Infective myocarditis on top of MELAS-cardiomyopathy first case description. , 2016, International journal of cardiology.